ZFIN ID: ZDB-FISH-180912-15
Fish name: pkd1azf1067/zf1067
Genotype: pkd1azf1067/zf1067
Targeting Reagent: none
HUMAN DISEASE MODELED by pkd1azf1067/zf1067
Human Disease Conditions Citations
autosomal dominant polycystic kidney disease standard conditions Zhu et al., 2017
GENE EXPRESSION
Gene expression in pkd1azf1067/zf1067
RNA expression No data available
Reporter gene expression No data available
PHENOTYPE
Phenotype in pkd1azf1067/zf1067
Phenotype Conditions Figures
heart edematous, abnormal standard conditions Fig. 1 from Zhu et al., 2017
pronephric duct cystic, abnormal standard conditions Fig. 1Fig. 6 from Zhu et al., 2017
pronephric duct cystic, ameliorated chemical treatment by environment: carbamazepine, chemical treatment by environment: sirolimus Fig. 6 from Zhu et al., 2017
pronephric duct cystic, ameliorated chemical treatment by environment: carbamazepine Fig. 6 from Zhu et al., 2017
pronephric duct cystic, ameliorated chemical treatment by environment: minoxidil Fig. 6 from Zhu et al., 2017
pronephric duct cystic, ameliorated chemical treatment by environment: sirolimus Fig. 6 from Zhu et al., 2017
pronephric duct cystic, ameliorated chemical treatment by environment: bafilomycin A1 Fig. 6 from Zhu et al., 2017
pronephric duct cystic, exacerbated standard conditions Fig. 1 from Zhu et al., 2017
pronephric duct has fewer parts of type pronephric duct autophagosome, abnormal chemical treatment by environment: bafilomycin A1 Fig. 2 from Zhu et al., 2017
pronephric duct morphology, normal standard conditions Fig. 4 from Zhu et al., 2017
pronephric duct autophagy decreased occurrence, abnormal chemical treatment by environment: bafilomycin A1 Fig. 2 from Zhu et al., 2017
pronephric duct regulation of autophagy process quality, abnormal standard conditions Fig. 2 from Zhu et al., 2017
pronephric tubule dilated, abnormal standard conditions Fig. 1 from Zhu et al., 2017
pronephros renal filtration decreased occurrence, abnormal standard conditions Fig. 1Fig. 6 from Zhu et al., 2017
pronephros renal filtration occurrence, ameliorated chemical treatment by environment: bafilomycin A1 Fig. 6 from Zhu et al., 2017
pronephros renal filtration occurrence, ameliorated chemical treatment by environment: sirolimus Fig. 6 from Zhu et al., 2017
pronephros renal filtration occurrence, ameliorated chemical treatment by environment: minoxidil Fig. 6 from Zhu et al., 2017
pronephros renal filtration occurrence, ameliorated chemical treatment by environment: carbamazepine Fig. 6 from Zhu et al., 2017
pronephros development decreased process quality, abnormal standard conditions Fig. 1Fig. 4 from Zhu et al., 2017
TOR signaling increased occurrence, abnormal standard conditions Fig. 2 from Zhu et al., 2017
whole organism Ab6-mtor labeling increased amount, abnormal standard conditions Fig. 2 from Zhu et al., 2017

CITATIONS  (1)